Also trades as: TLT.V (TSXV) · $vol 0M
TLTFF OTC
Theralase Technologies Inc.
1W: +1.2%
1M: -7.6%
3M: -35.3%
YTD: -5.0%
1Y: -8.2%
3Y: -21.7%
5Y: -30.4%
$0.13
+0.00 (+0.28%)
Weekly Expected Move ±5.1%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$3M
-0.9% ▼
5Y CAGR: -26.8%
Total Liabilities
$1M
-14.0% ▼
5Y CAGR: -6.1%
Shareholders Equity
$2M
+8.5% ▲
5Y CAGR: -31.6%
Cash & Investments
$269K
+512.0% ▲
5Y CAGR: -53.6%
Total Debt
$294K
-24.0% ▼
5Y CAGR: +15.2%
Net Debt
$25K
-92.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $8M | $4M | $2M | $44K | $269K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $8M | $4M | $2M | $44K | $269K |
| Net Receivables | $175K | $86K | $196K | $388K | $547K |
| Inventory | $452K | $566K | $486K | $658K | $545K |
| Other Current Assets | $310K | $214K | $241K | $198K | $222K |
| Total Current Assets | $9M | $5M | $3M | $1M | $2M |
| Property, Plant & Equip. | $1M | $866K | $1M | $858K | $606K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $64K | $81K | $553K | $920K | $1M |
| Total Non-Current Assets | $1M | $947K | $2M | $2M | $2M |
| Total Assets | $10M | $6M | $4M | $3M | $3M |
| — Liabilities — | |||||
| Accounts Payable | $408K | $496K | $328K | $682K | $362K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $12K | $0 | $0 |
| Total Current Liabilities | $821K | $875K | $681K | $1M | $986K |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $36K | $0 | $387K | $294K | $194K |
| Total Liabilities | $857K | $875K | $1M | $1M | $1M |
| — Equity — | |||||
| Common Stock | $42M | $42M | $45M | $46M | $49M |
| Retained Earnings | -$49M | -$53M | -$58M | -$63M | -$67M |
| Accumulated OCI | $5M | $5M | $6M | $6M | $3M |
| Total Stockholders Equity | $9M | $5M | $3M | $2M | $2M |
| Total Liabilities & Equity | $10M | $6M | $4M | $3M | $3M |
| — Key Metrics — | |||||
| Total Debt | $92K | $36K | $474K | $387K | $294K |
| Net Debt | -$8M | -$4M | -$1M | $343K | $25K |
| Total Investments | $0 | $0 | $0 | $0 | $0 |